Antioxidanter forskningsreferencer

Januar 1999

1. Abbott RA, Cox M, Markus H, Tomkins A. Diet, body size and micronutrient status in Parkinson’s disease. Eur J Clin Nutr 46:879-84, 1992.
2. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-22.
3. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci. USA 1995; 92: 5258-65.
4. Azen SP, Qian D, Mack W, et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94;10:2369-72, 1996.
5. Bhat KS. Nutritional status of thiamine, riboflavin and pyridoxine in cataract patients. Nutr Rep Int 363:685-92, 1987.
6. Boers GH. Hyperhomocysteinaemia: A newly recognized risk factor for vascular disease. Neth J Med 45:1:34-41, 1994.
7. Boniton-Kopp C, Coudray C, Berr C, et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The Eva study. Am J Clin Nutr 65:121-7, 1997.
8. Brattström L. Vitamins as homocysteine-lowering agents: A mini review. Presentation at the American Institute of Nutrition Colloquium, April 13, 1995, Atlanta, Georgia; Brattström L. Vitamins as homocysteine-lowering agents. J Nutr 126:4 Suppl:1276S-1280S, 1996.
9. Calzada C, Bruckdorfer K, Rice-Evans C. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 128;1: 97-105, 1997.
10. Cerhan JR, Wallace RB, Folsom AR. Antioxidant intake and risk of Parkinson’s Disease in older women. Am J Epidemiol 139;11:S65, 1994.
11. De Lorgeril , Boissonnat P, Salen P, et al. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients. Transplantation 58:193-4, 1994.
12. De Rijk MC et al. Dietary antioxidants and Parkinson disease: The Rotterdam study. Arch Neurology 54:762-5, 1997.
13. Ely J. Crary, Smyrna, Georgia, USA – quoted in Zarrow S. Keep your eyes young and sharp. Prevention March, 1985, pp. 74-80; Crary E. Antioxidant treatment of macular degeneration of the aging and macularedema in diabetic retinopathy. South Med J 80 no. 9, supple 3:38, 1987.
14. Fahn S. An open trial of high-dosage antioxidants in early Parkinson’s disease. Am J Clin Nutr 53:380S-1S, 1991.
15. Gartside PS, Glueck CJ. Relationship of dietary intake to hospital admission for coronary heart and vascular disease: The NHANES II National Probability Study. J Am Coll Nutr 12:6:5676-84, 1993.
16. Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: A hospital-based case-control study. J Nutr Environ Med 5:235-42, 1995.
17. Grimes JD et al. Prevention of progression of Parkinson’s disease with antioxidative therapy. Prog Neuropsychopharmacol Biol Psychiatry 122-3:165-72, 1988.
18. Hankinson S, Stampfer M, Seddon J, et al. Nutrient intake and cataract extraction in women: A prospective study. BMJ 305: 335-9, 1992.
19. Heliovaara M, Knekt P, Aho K, et al. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53: 51-3, 1994.
20. Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273;23:1849-54, 1995.
21. Ince S. Vitamin Supplements may help delay onset of AIDS. Medical Tribune September 9, p.18, 1993.
22. Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 106:3:337-40, 1988.
23. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 53: 352S-5S, 1991.
24. Jacques PH et al. Vitamin intake and senile cataract. J Am Coll Nutr 6:5:435, 1987.
25. Jain VK, Chandra RK. Does nutritional deficiency predispose to Acquired Immune Deficiency Syndrome (AIDS)? Nutr Res 4:537-43, 1984.
26. Jariwalla RJ. Micro-nutrient imbalance in HIV infection and AIDS: Relevance to pathogenesis and therapy. J Nutr Environ Med 5:297-306, 1995.
27. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in an longitudinal population study. Am JEpidemiol 139:1180-9, 1994.
28. Knekt P, Heliovaara M, Rissanan A, et al. Serum antioxidant vitamins and risk of cataract. BMJ 305:1392-4, 1992.
29. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness: The ARIC study. Circulation 92:8:2142-50, 1995.
30. Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Abstract. J Am Coll Nutr 11:5:633, 1992.
31. Mares-Perlman J, Klein R, Klein B, et al. Relationship between age-related maculopathy and intake of vitamin and mineral supplements. Invest Ophthalmol Vis Sci 34:1133, 1993.
32. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 39(4): 648-56,1996.
33. Mastroiacovo P et al. Antioxidant Vitamins and Immunodeficiency. Int J Vitam Nutr Res 66:141-5, 1996.
34. Mooradian AD et al. Selected Vitamin and Mineral in Diabetes. Diabetes Care 17; 464-79, 1994.
35. Newsome D et al. The trace element and antioxidant economy of the human macula: Can dietary supplementation influence the course of macular degeneration? J Am Coll Nutr 10:5:536, 1991.
36. Olson RJ. Supplemental dietary antioxidant vitamins and minerals in patients with macular degeneration. J Am Coll Nutr 10:5:550, 1991.
37. Olszewski AJ et al. Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 75:1:1-6, 1989.
38. Pories WJ, Henzel JH, Hennessen JA. Proc U of Missouri First Annual Conference on Trace Substances in the Environment and Health 1968:114, 1967.
39. Rath M, Pauling L. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Orthomol Med 7:1:5-15, 1992.
40. Singh R, Niaz M, Bishnol J, et al. Diet, antioxidant vitamins, oxidative stress, and risk of coronary artery disease. Acta Cardiol 49:5:453-67, 1994.
41. Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant vitamins and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol 76:1233-8, 1995.
42. Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: A hospital-based case-control study. J Nutr Environ Med 5:235-42, 1995.
43. Singal PK, Kapur N, Dhillon KS et al. Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 60:1390, 1982.
44. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62:suppl:1448S-61S, 1995.
45. Steinberg D.Antioxidants in the prevention of human Artherosclerosis. Circulation 85; 6; 2338-2344, 1992.
46. Tang A, Graham N, Kirby A, et al. Dietary micronutrient intake and the risk of progression to Acquired Immunodeficiency Syndrome (AIDS) in Human Immunodeficiency Virus Type 1 (HIV-1) infected homosexual men. Am J Epidemiol 138: 937-51, 1993.
47. Tang AM, Graham NM, Saah AJ. Effects of Micronutrient Intake on Survival in Human immunodeficiency virus type 1 Infection. Am J Epidemiol 143:1244-56, 1996.
48. Tavani A et al. Food and nutrient intake and risk of cataract. Ann Epidemiol 6:41-6, 1996.
49. Tolonen, Matti: Fria radikaler och antioxidantia i biologi och medicin. Vitaminers og spormineralers betydning for velfærdssygdomme. (Significance of vitamins and traceminerals in disease), Rigshospitalets Symposium, Pharma Nord Research, 1988 (in Danish/Swedish).
50. Vitale S, West S, Hallfrish H, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 4:195-203, 1993.
Ward RJ et al. Reduced antioxidant status in patients with chronic alcoholic myopathy. Biochem Soc Trans 16:581, 1988.
51. Ward RJ, Peters TJ. The antioxidant status of patients with either alcohol-induced liver damage or myopathy. Alcohol Alcohol 27;4:359-65, 1992.
52. Weisberger JH. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr 1995; 53: 226s.
53. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 112:222-7, 1994.
54. Woodside J et al. The effects of vitamin supplementation on cardiovascular risk. J Inherit Metabol Dis 19:Suppl 1:26/P51, 1996.

– Se også betacaroten, B6-vitamin, C-vitamin, E-vitamin, Q10, selen og zink.

Kilder:
Joseph E. Pizzorno Jr., Michael T. Murrey & Melvyn R. Werbach.